Medicina
Departamento
Tongji University
Shangai, ChinaPublicaciones en colaboración con investigadores/as de Tongji University (11)
2023
-
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
New England Journal of Medicine, Vol. 389, Núm. 22, pp. 2039-2051
2022
-
Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?
Frontiers in Cardiovascular Medicine
2021
-
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
The Lancet, Vol. 398, Núm. 10317, pp. 2149-2159
-
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review
Journal of the American College of Cardiology, Vol. 78, Núm. 8, pp. 840-853
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention: A Global Expert Consensus Document
Circulation, Vol. 140, Núm. 5, pp. 420-433
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Journal of Infection, Vol. 79, Núm. 4, pp. 300-311
-
Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
Lung Cancer, Vol. 132, pp. 126-131
2018
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study
ERJ Open Research, Vol. 4, Núm. 4
2010
-
Iloprost-different indications and different national experiences in treating pulmonary hypertension
Clinical Research in Cardiology Supplements, Vol. 5, Núm. SUPPL.2, pp. 19-23